Danaher Corporation

Healthcare

NYSE:DHR · New York Stock Exchange

Market Cap $127.36B Beta 0.83 P/E (TTM) 34.5

$179.95 -0.46%

-$0.84 today

52W Low $160.93High $242.80

Vol 1.36M · Avg 4.59M

EPS (TTM)$5.21

Div Yield0.76%

Medical - Diagnostics & Research

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-11.50%

Period High

$241.53

Period Low

$161.91

Latest

$180.28

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Amgen Inc.

NASDAQ:AMGN

$190.80B

Thermo Fisher Scientific Inc.

NYSE:TMO

$174.33B

Gilead Sciences, Inc.

NASDAQ:GILD

$155.36B

Pfizer Inc.

NYSE:PFE

$149.17B

Intuitive Surgical, Inc.

NASDAQ:ISRG

$144.55B

Stryker Corporation

NYSE:SYK

$120.21B

Sanofi

NASDAQ:SNY

$106.45B

Medtronic plc

NYSE:MDT

$103.09B

McKesson Corporation

NYSE:MCK

$94.82B

Boston Scientific Corporation

NYSE:BSX

$69.83B

What is the latest DHR filing?

The latest filing shown is S-8 dated Jun 9, 2026.

How many recent filings does DHR have?

Intrinsic Alpha currently shows 20 recent filings for DHR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.